OUR FIRM

Latest News

March 31, 2017

Guggenheim Securities Hires Adnan Butt to Expand Healthcare Coverage

NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Adnan Butt will join the firm as a Managing Director to expand Healthcare coverage on the Equities platform. Mr. Butt will join Guggenheim on the Healthcare research team in June, specifically focusing on biotechnology companies.

Mr. Butt joins Guggenheim from RBC Capital Markets, where he was a Biotechnology Analyst. Prior to RBC, he covered biotechnology at ThinkEquity Partners, Morgan Stanley, and J.P. Morgan & Co.

“We are excited for Adnan to join our team,” said Jerry Donini, Co-CEO of Guggenheim Securities. “His deep industry knowledge provides a significant expansion to our Healthcare platform, building on our existing research presence in specialty pharmaceuticals, major pharmaceuticals, biotechnology, and medical devices and supplies. We look forward to his success at Guggenheim.”

Mr. Butt received his M.A. in Economics from Trinity College and his M.A. in Neuroscience from the University of Hartford; he received his B.A. in Economic and Molecular Biology & Biochemistry from Wesleyan University. He will be based in Guggenheim’s San Francisco office.


About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $260 billion1 in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With 2,300 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.

1Assets under management as of 12.31.2016 and include consulting services for clients whose assets are valued at approximately $63bn.


Media Contact

Ellen Cunningham
Guggenheim Partners
212.518.9578
Ellen.N.Cunningham@GuggenheimPartners.com



June 11, 2021

Guggenheim Partners Appoints Gerald Donini A Managing Partner

NEW YORK, NY – Guggenheim Partners, the global financial services firm, today named its Chief Operating Officer, Gerald Donini, a Managing Partner of the firm.

Read More

May 21, 2021

Benjamin Wilson Joins Guggenheim Securities as Senior Managing Director in its Mergers & Acquisitions Advisory Practice

NEW YORK, NYGuggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Benjamin Wilson has joined the firm as a Senior Managing Director in its Mergers & Acquisitions advisory practice. Mr. Wilson is based out of Guggenheim’s New York office.

Read More

May 17, 2021

Guggenheim Securities Hires Dino Dedić to Expand Healthcare Investment Banking Practice

NEW YORK, NYGuggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Dino Dedić has joined the firm as a Senior Managing Director to expand coverage in its healthcare investment banking group. Mr. Dedić will focus on advising companies in the pharmaceutical services and animal health sectors.

Read More